Memphasys Limited (ASX:MEM)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Sep 18, 2026, 4:10 PM AEST
Memphasys Revenue
In the fiscal year ending June 30, 2026, Memphasys had annual revenue of 657.97K AUD with 24.87% growth. Memphasys had revenue of 645.56K in the half year ending June 30, 2026.
Revenue
657.97K
Revenue Growth
+24.87%
P/S Ratio
28.15
Revenue / Employee
27.42K
Employees
24
Market Cap
18.52M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 657.97K | 131.05K | 24.87% |
| Jun 30, 2025 | 526.92K | 370.92K | 237.77% |
| Jun 30, 2024 | 156.00K | -468.37K | -75.01% |
| Jun 30, 2023 | 624.37K | 53.29K | 9.33% |
| Jun 30, 2022 | 571.08K | 359.60K | 170.04% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compumedics | 61.88M |
| Nova Eye Medical | 34.87M |
| CleanSpace Holdings | 19.82M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| CurveBeam AI | 8.67M |
| CONNEQT Health | 7.96M |
| Atomo Diagnostics | 5.33M |